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Population
Fetuses carried to term, or healthy term infants under 1 year of age, without recurrent wheeze or asthma. *Since both prenatal and postnatal exposure to probiotics will be considered, the population may comprise mother-infant pairs, where the mother received probiotics during pregnancy.
Intervention
Probiotics (live microorganisms consumed for their presumed health benefits): any strain, preparation or dose, administered with or without prebiotics.
Comparator
Any comparator including active comparator (non-probiotic), no intervention, or placebo.
Outcomes

Primary Outcome:
Incidence of doctor-diagnosed asthma.
Secondary Outcomes:
Incidence of parent-reported asthma.
Incidence of wheeze (parent-reported or clinically-diagnosed). Asthma Predictive Index score. Incidence of hospitalization for asthma. Incidence of asthma medication use. Incidence of lower respiratory tract infection (rationale: these infections generally include wheeze).
Safety Outcomes:
Severe gastrointestinal disturbances Allergic reaction to probiotic Withdrawal due to perceived side effects
Study design
Prospective randomized controlled trials. S4 Figure S1 . Summary risk of bias assessment. Included trials (n=20) were assessed for internal validity using the Cochrane Collaboration's Risk of Bias tool (see also Table S4 ), which evaluates 7 sources of bias across 6 domains. The percentage of trials adjudicated to be of low, unclear and high risk of bias, for each domain, are shown here.
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